Trump Unveils Historic Drug Pricing Pact with Pharmaceutical Giants
Published on: April 24, 2026, 1:50 a.m. | Source: Devdiscourse
President Donald Trump has secured a landmark drug pricing agreement with Regeneron and other major pharmaceutical companies, reducing medication costs for Medicaid and cash payers. In exchange for tariff exemptions, the deal includes 'most-favored nation' pricing and significant U.S. investments. Regeneron will also offer Praluent at a reduced price.
